We test this hypothesis using the xCell-gene-signature-based method to infer CD8 T cell abundance in the tumor of large cohorts with publicly available data—The Cancer Genome Atlas (TCGA), Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), and multiple Gene Expression Omnibus (GEO) cohorts. The gene discussed is CD8A; the disease is breast carcinoma.